Global Liver Institute
Fatty Liver Disease News
GLOBAL LIVER INSTITUTE

Stay up-to-date with the latest in the fatty liver disease field and subscribe to our monthly newsletters today!
Beyond the Diagnosis: Stories, Breakthroughs & Global Action – Fatty Liver Disease News
As of January 2025, major changes to Medicare Part D under the Inflation Reduction Act are now in effect, making prescription drugs more affordable for millions of patients.
What’s New in 2025 – Fatty Liver Disease News
As of January 2025, major changes to Medicare Part D under the Inflation Reduction Act are now in effect, making prescription drugs more affordable for millions of patients.
The Most Common Chronic Liver Disease in the World – Fatty Liver Disease News
Last month, the GLI team proudly attended AASLD’s The Liver Meeting™, starting with our 10th anniversary celebration, which brought together patient advocates, industry leaders, and liver community members to celebrate a decade of impactful work.
Screening for MASLD is Cost-Effective for Patients – Fatty Liver Disease News
In this issue, we explore recent findings that highlight the need for dietary changes, including the link between ultra-processed foods and metabolic disorders in children with obesity, as well as the benefits of increasing plain water intake can reduce mortality risk.
Emerging Evidence in Liver Health: GLP-1, Pollution, and More – Fatty Liver Disease News
Despite awareness efforts, fatty liver disease remains largely overlooked in major global health strategies.
New Guidelines & Actions for Change – Fatty Liver Disease News
New Clinical Practice Guidelines for MASLD, developed jointly by EASL, EASD, and EASO, update the 2016 guidelines to reflect recent advancements.